BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 06, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Donepezil regulatory update

Ranbaxy said FDA approved generic versions of 5 and 10 mg donepezil to treat Alzheimer's disease in the U.S. ...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >